tiprankstipranks
Advertisement
Advertisement

ANRO Stock Latest News

Alto Neuroscience Appoints Andrew Miller to Board
Company AnnouncementsAlto Neuroscience Appoints Andrew Miller to Board
12d ago
8K
ANRO
Alto Neuroscience appoints Miller to Board of Directors
PremiumThe Fly
Alto Neuroscience appoints Miller to Board of Directors
12d ago
ANRO
Alto Neuroscience Buy Rating Reiterated as Analyst Highlights De-Risked Pipeline, Strong Cash Runway and Maintains $50 Price Target
PremiumRatings
Alto Neuroscience Buy Rating Reiterated as Analyst Highlights De-Risked Pipeline, Strong Cash Runway and Maintains $50 Price Target
13d ago
ANRO
Alto Neuroscience price target lowered to $33 from $35 at BofA
PremiumThe Fly
Alto Neuroscience price target lowered to $33 from $35 at BofA
18d ago
ANRO
Alto Neuroscience price target lowered to $36 from $38 at Baird
PremiumThe Fly
Alto Neuroscience price target lowered to $36 from $38 at Baird
22d ago
ANRO
Alto Neuroscience price target raised to $24 from $21 at Wedbush
PremiumThe FlyAlto Neuroscience price target raised to $24 from $21 at Wedbush
25d ago
ANRO
Alto Neuroscience: Buy Rating Reiterated as Lead Asset Advances and Cash Runway Extends; $28 Price Target Maintained
Premium
Ratings
Alto Neuroscience: Buy Rating Reiterated as Lead Asset Advances and Cash Runway Extends; $28 Price Target Maintained
26d ago
ANRO
Ritu Baral Reiterates Buy on Alto Neuroscience, Citing Pivotal ALTO-207 Phase 2b Trial in TRD and Strong Cash Runway Through 2029
Premium
Ratings
Ritu Baral Reiterates Buy on Alto Neuroscience, Citing Pivotal ALTO-207 Phase 2b Trial in TRD and Strong Cash Runway Through 2029
26d ago
ANRO
Alto Neuroscience Shareholders Shape Governance and Equity Plans
PremiumCompany Announcements
Alto Neuroscience Shareholders Shape Governance and Equity Plans
26d ago
8K
ANRO
Alto Neuroscience reports Q1 EPS (80c) vs (56c) last year
PremiumThe Fly
Alto Neuroscience reports Q1 EPS (80c) vs (56c) last year
27d ago
ANRO
Alto Neuroscience initiated with a Buy at BofA
PremiumThe Fly
Alto Neuroscience initiated with a Buy at BofA
1M ago
ANRO
Alto Neuroscience presents Phase 2a data for ALTO-207 in MDD
PremiumThe Fly
Alto Neuroscience presents Phase 2a data for ALTO-207 in MDD
1M ago
ANRO
Alto Neuroscience participates in a conference call with H. C. Wainwright
PremiumThe FlyAlto Neuroscience participates in a conference call with H. C. Wainwright
1M ago
ANRO
Alto Neuroscience initiates Phase 2b trial of ALTO-207 in TRD
Premium
The Fly
Alto Neuroscience initiates Phase 2b trial of ALTO-207 in TRD
2M ago
ANRO
Alto Neuroscience files to sell 6M shares of common stock for holders
Premium
The Fly
Alto Neuroscience files to sell 6M shares of common stock for holders
2M ago
ANRO
Alto Neuroscience’s ALTO-101 miss doesn’t impact thesis, says H.C. Wainwright
PremiumThe Fly
Alto Neuroscience’s ALTO-101 miss doesn’t impact thesis, says H.C. Wainwright
2M ago
ANRO
Alto Neuroscience price target lowered to $21 from $22 at Wedbush
PremiumThe Fly
Alto Neuroscience price target lowered to $21 from $22 at Wedbush
2M ago
ANRO
Morning Movers: Immunovant sinks after batoclimab trials miss goal
PremiumThe Fly
Morning Movers: Immunovant sinks after batoclimab trials miss goal
2M ago
BP
ALK
Alto Neuroscience price target lowered to $38 from $41 at Baird
PremiumThe Fly
Alto Neuroscience price target lowered to $38 from $41 at Baird
2M ago
ANRO
Alto Neuroscience price target lowered to $44 from $49 at JonesResearch
PremiumThe FlyAlto Neuroscience price target lowered to $44 from $49 at JonesResearch
2M ago
ANRO
Closing Bell Movers: Globalstar spikes on acquisition report
Premium
The Fly
Closing Bell Movers: Globalstar spikes on acquisition report
2M ago
FC
AMZN
Alto Shifts Focus to ALTO-207 After ALTO-101 Data
Premium
Company Announcements
Alto Shifts Focus to ALTO-207 After ALTO-101 Data
2M ago
8K
ANRO

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >